Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a bone drug be the key to stopping falls in the elderly?

NCT ID NCT06118905

Summary

This study is testing if a medication already approved for treating osteoporosis (Denosumab) can also help preserve muscle strength and function in frail older adults. The goal is to see if this drug can reduce the risk of falls and fractures in this vulnerable group. Researchers will compare it to another standard osteoporosis treatment in about 155 men and women aged 65 and older living in long-term care facilities.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOPOROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • St. Barnabas Woodlands

    RECRUITING

    Pittsburgh, Pennsylvania, 16059, United States

    Contact

Conditions

Explore the condition pages connected to this study.